The Evolving Landscape of Digital Biomarkers & Wearable Sensors

The term “digital biomarkers” is everywhere. New biomarker-focused conferences, journals, and regulatory requirements abound, but it seems like such a broad subject.

In this webinar, we discuss the digital biomarker landscape and examine them more specifically in the context of wearables in clinical trials:

• Why are digital biomarkers important?
• What do pharma sponsors want?
• What can the academic community provide?
• Are there any examples? What can we do right now?

Presented by

• Jeremy Wyatt, CEO
• Rob Wilson, SVP Business Development and Corporate Strategy
• Tyler Guthrie, Director of Scientific Affairs and Data Management

Duration: 1 Hour

Published Date

 September 18, 2018

---

Attachment:

 The-Evolving-Landscape-of-Digital-Biomarkers-Wearable-Sensors.pdf

---

Suggest a Webinar